Pfizer

Pfizer creates value by investing in drug discovery, clinical development, regulatory approval, large-scale manufacturing and global commercial distribution. It monetises approved products through product sales to healthcare channels and institutional buyers, with additional value potentially supported by licensing, partnerships and lifecycle extensions around its intellectual property.

Pfizer is a global pharmaceutical company that researches, develops, manufactures and commercialises prescription medicines and vaccines. It primarily generates revenue by selling branded and, where applicable, off-patent healthcare products through healthcare systems, wholesalers, pharmacies, hospitals, governments and other institutional buyers.

The company serves healthcare providers, payers and public-sector procurement bodies rather than operating as a marketing, media or software business. Its economics are driven by product sales, intellectual property, regulatory approvals, manufacturing scale and lifecycle management of drug portfolios.